Prior Knowledge, Knowledge Management and QTPP Development
Quality by Design for biotech products and small molecules
Experimental Work, Multi-variate Data Analysis (MVA) and Knowledge Space Establishment
Initial Risk Assessment (FMEA), Introduction to Process Characterisation and Design of Experiments
Control StrategyTechnologies Assisting QbD Approach
Design Space Definition
Post-Approval Change Management Protocol
Regulatory Flexibility and QbD submission strategies
Who should Attend
Pharmaceutical scientists, chemists, biologists and engineers Experts from industry (pharmaceutical companies, biotech companies, generic industry) Regulators with experience in pharmaceutical, chemical and biotech development, manufacturing, quality assurance and CMC
Past Events
Quality by Design 2015 - 21-23 Sep 2015, Pharmig Academy, Vienna, Austria (52813)
Quality by Design 2026
Important
Please, check "Quality by Design" official website for possible changes, before making any traveling arrangements
